Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid.
about
sameAs
Chemotherapy- and irradiation-induced bone loss in adults with solid tumorsContribution of acidic extracellular microenvironment of cancer-colonized bone to bone painProstate cancer and bone: the elective affinities.Patients' preferences for bone metastases treatments in France, Germany and the United Kingdom.Targeting bone metabolism in patients with advanced prostate cancer: current options and controversies.Acidic microenvironment and bone pain in cancer-colonized boneValidation of International Classification of Diseases coding for bone metastases in electronic health records using technology-enabled abstractionPain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases.Burden of symptoms associated with development of metastatic bone disease in patients with breast cancerPatient, Caregiver, and Nurse Preferences for Treatments for Bone Metastases from Solid Tumors.Contemporary pharmacotherapy for the prevention of skeletal complications in patients with prostate cancer.Pain outcomes in patients with bone metastases from advanced cancer: assessment and management with bone-targeting agents.Evidence on the analgesic role of bisphosphonates and denosumab in the treatment of pain due to bone metastases: A systematic review within the European Association for Palliative Care guidelines project.The incidence of bone metastasis after early-stage breast cancer in Canada.An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three European countries.Bone Pain Induced by Multiple Myeloma Is Reduced by Targeting V-ATPase and ASIC3.Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events.Assessing the benefit of bone-targeted therapies in prostate cancer, is the devil in the end point's definition?Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective study.Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in real-world practice in six European countries.A Systematic Review of Clinical Practice Guidelines for Castration-Resistant Prostate Cancer.Physicians' preferences for bone metastases treatments in France, Germany and the United Kingdom.
P2860
Q28084019-9D7E390E-513C-47F4-BB63-B6293852B58DQ28085753-FA1F2480-F7C7-4927-B7FF-7D7A69521650Q33757791-0490FB7E-BF63-4DB4-AE5B-F10C18136969Q34718400-59CAD76D-80F3-4685-ABFF-C0A01E16FF14Q35087364-C6C4F6BA-B2B1-489D-B829-226F6C78E0DEQ35575632-3408F107-3DA5-42A2-910E-F004F12F354FQ36284104-2C147B9D-88EB-4722-8D59-DF8D8F16ED57Q36510928-A6B642F5-F0B8-444E-94B3-4A91CA7DA51DQ37030106-8BA161BA-399A-4167-AE30-C9D1DED2881CQ37048841-02BFE601-1363-4F16-886C-E8A87ECD2DD0Q38252425-96985071-0D72-4084-9A50-E441A8B125C8Q38297692-4C239868-938A-4561-AC9B-A3F16E1C3C81Q38785899-9C1DA5AC-FB2C-4D1B-B133-1F94F8174BFCQ39847750-34D9BCCF-8952-43A2-A3F5-8BE5F98A4EAEQ41125390-DD27AD77-7864-4B13-AE55-0753CE26D4F9Q41729858-B910FA81-7789-4C5D-86BC-B9B64D6F8804Q42274691-764C0CC8-94AE-4485-902F-936393CEDFF6Q53675120-6CF179B4-97E2-4D64-8679-9F218CD5DA30Q54941803-C35EC056-4BDD-4E8E-B157-9EAD17780E01Q55114445-855A8783-C973-4641-B11B-5D245242A591Q55158890-75673865-DC85-48F1-97AC-AC082A5A086AQ55518625-6B40D3F9-47EA-4816-833E-8836AFB3EED9
P2860
Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Pain and health-related qualit ...... denosumab and zoledronic acid.
@en
Pain and health-related qualit ...... denosumab and zoledronic acid.
@nl
type
label
Pain and health-related qualit ...... denosumab and zoledronic acid.
@en
Pain and health-related qualit ...... denosumab and zoledronic acid.
@nl
altLabel
Pain and health-related qualit ...... denosumab and zoledronic acid
@en
prefLabel
Pain and health-related qualit ...... denosumab and zoledronic acid.
@en
Pain and health-related qualit ...... denosumab and zoledronic acid.
@nl
P2093
P2860
P1476
Pain and health-related qualit ...... denosumab and zoledronic acid
@en
P2093
Alison Stopeck
Blair Egerdie
Charles S Cleeland
Cleeland CS
Damyanov D
P2860
P2880
P2888
P304
P356
10.1007/S00520-013-1932-2
P577
2013-08-22T00:00:00Z
2013-12-01T00:00:00Z